针对产金属 β- 内酰胺酶（MBL）铜绿假单胞菌感染治疗难题，研究用头孢吡肟 / 齐德巴坦治疗患者获临床和微生物学治愈 ...

The frequency of neutropenia in patients receiving long-term cefepime therapy for osteomyelitis compared with that in patients receiving other antimicrobials was studied. A comparative case review ...

The FDA has given the green light to Exblifep, based on long-established beta-lactam antibiotic cefepime and a new extended-spectrum beta-lactamase inhibitor (BLI) called enmetazobactam ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

† Dose injected directly into vein or running intravenous fluids. ‡ Intermittent intravenous infusion. § Aminoglycosides are not recommended for patients with renal insufficiency as less ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

This further validates the facility’s compliance with European regulatory requirements and its capability to serve global markets. Read also: DCGI nod to Orchid Pharma Antibiotic Drug Combination of ...

Three of these six pathogens are antibiotic-resistant Gram-negative bacteria. Recently, antibacterial drugs against ESBL-producing Gram-negative bacteria accounted for ∼15% (2 out of 13) of all ...

Its lead combination - cefepime-taniborbactam – is being developed in phase 3 trials for complicated urinary tract infections (cUTI), hospital-acquired bacterial pneumonia, and ventilator ...